AngioDynamics | ANGO - Ebitda


AngioDynamics reported $5.94M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Boston Scientific USD 1.16B 213M Dec/2025
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
ICU Medical USD 98.68M 489K Mar/2026
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Smiths 331M 30M Jun/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024